Delivra Health Posts Steady Growth, Sees Success With Strong Marketing Push Proactive

Content provided by Proactive Investors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Proactive Investors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Proactive - Interviews for investors »
Delivra Health posts steady growth, sees success with strong marketing push

17h ago 3:28

MP3•Episode home

Delivra Health Brands CEO Gord Davey joined Steve Darling from Proactive to share highlights from the company’s financial and operational results for the three and nine months ended March 31, 2025. The company reported positive adjusted EBITDA and a 3% year-over-year revenue increase in the third fiscal quarter—reflecting strong financial discipline and a focus on high-impact growth initiatives. Davey emphasized Delivra Health’s ongoing commitment to strategic investment, with a focus on brand innovation, marketing expansion, and increasing market visibility. As part of this strategy, the company has expanded its flagship Dream Water brand in Canada with new line extensions, including enhancements to its Sleep Shot offerings. In a significant product development move, Delivra introduced Sleep Gummies in both a 6-count convenience pack and a 60-count multi-pack, catering to consumer demand across a wide variety of retail formats. These new SKUs are now available through major retailers such as Shoppers Drug Mart, Loblaws, Circle K, and within Canada’s airport retail channels, strengthening the company’s presence in travel and everyday wellness categories. Supporting these efforts, the company launched its new digital marketing campaign titled “Quiets Chronic Pain”, which has delivered strong engagement and broad reach across multiple platforms. The campaign’s success helped drive a 21% year-over-year increase in unit sales, rising from 78,000 units in the previous year to approximately 95,000 units in the current period. Davey noted that Delivra Health remains focused on sustainable growth through innovation, market expansion, and deeper customer engagement—positioning the company well for continued momentum in 2025 and beyond. #proactiveinveestors #delivrahealthbrandsinc #tsxv #dhb #otcqb #dhbuf #DreamWater #GlobalExpansion #UAE #MiddleEastMarket #SleepAid #HealthAndWellness #PharmacyProducts #RegulatoryCompliance #DreamWater #SleepGummies #Wellness #SleepAid #TravelEssentials #CanadianRetail #HealthAndWellness #InsomniaRelief #SleepBetter #DreamWater #ConsumerHealth #GlobalExpansion #GordDavey #HealthAndWellness #LivRelief #EarningsUpdate #MarketingStrategy #SleepAid #PainRelief #Investing #TSXV

605 episodes

#Trading #Business News #Business #News #Proactive Investors #Gold #Cannabis #Battery Metals #Chief Executive #Biotech #Natural Resources #Bitcoin #Cryptocurrency #Interviews #Investing #Investment Research #Mining #Retail Investment #Technology